Filing Flows › Comparisons › VNRX vs CDIO
Volitionrx vs Cardio Diagnostics Holdings: VNRX and CDIO compared
Volitionrx is the larger company: $399K of revenue in its latest quarter (Q2 2026) against $4K for Cardio Diagnostics Holdings (Q3 2026). Cardio Diagnostics Holdings is growing faster (+26% against -2% a year earlier).
Where the money goes: VNRX and CDIO
Volitionrx (VNRX) · Q2 2026
Volitionrx, Q2 2026: revenue $399K (-2% year over year), net loss $7.3M, operating cash flow −$5.2M. The chart follows the revenue to costs, profit and cash.
Cardio Diagnostics Holdings (CDIO) · Q3 2026
Cardio Diagnostics Holdings, Q3 2026: revenue $4K (+26% year over year), net loss $1.7M, operating cash flow −$1.5M. The chart follows the revenue to costs, profit and cash.
| Volitionrx (VNRX) | Cardio Diagnostics Holdings (CDIO) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $399K | $4K |
| Revenue growth, Y/Y | -2% | +26% |
| Operating margin | n/m | n/m |
| Net earnings | −$7.3M | −$1.7M |
| Operating cash flow | −$5.2M | −$1.5M |
Questions
Which is bigger, Volitionrx or Cardio Diagnostics Holdings?
Volitionrx is the larger company: $399K of revenue in its latest quarter (Q2 2026) against $4K for Cardio Diagnostics Holdings (Q3 2026).
Is Volitionrx or Cardio Diagnostics Holdings growing faster?
Cardio Diagnostics Holdings is growing faster (+26% against -2% a year earlier).
More: Volitionrx earnings · how Volitionrx makes money · Cardio Diagnostics Holdings earnings · how Cardio Diagnostics Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.